Colorectal Cancer Genomic Biomarkers in the Clinical Management of Patients With Metastatic Colorectal Carcinoma

doi 10.37349/etat.2020.00004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Open Exploration Publishing

Related search

Biomarkers in the Management of Metastatic Colorectal Cancer- A Mini Review

Biomedical Journal of Scientific & Technical Research
2019English

Current and Emerging Biomarkers in Metastatic Colorectal Cancer

Current Oncology
Oncology
2019English

Reolysin® Enters Clinical Trial for Patients With Metastatic Colorectal Cancer

Immunotherapy
OncologyAllergyImmunology
2009English

Haemostatic Biomarkers for Prognosis and Prediction of Therapy Response in Patients With Metastatic Colorectal Cancer

Thrombosis Research
Hematology
2020English

Clinical Implication of Concordant or Discordant Genomic Profiling Between Primary and Matched Metastatic Tissues in Patients With Colorectal Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Trefoil Factor Family (TFF) Proteins as Potential Serum Biomarkers in Patients With Metastatic Colorectal Cancer.

Neoplasma
Cancer Research
2015English

Transarterial Chemoembolisation in the Treatment of Patients With Metastatic Colorectal Cancer

I.P. Pavlov Russian Medical Biological Herald
2018English

RAS and BRAF in Metastatic Colorectal Cancer Management

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2016English

Major Surgery in Patients With Metastatic Colorectal Cancer in Western Europe

Journal of Gastrointestinal Cancer
OncologyGastroenterology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy